A. Güntert

发表

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.

Susan M Resnick, Magda Tsolaki, Luigi Ferrucci, 2010, Archives of general psychiatry.

Plasma gelsolin is decreased and correlates with rate of decline in Alzheimer's disease.

Muzamil Saleem, Simon Lovestone, S. Lovestone, 2010, Journal of Alzheimer's disease : JAD.

Characterization of amyloid-ß and other proteins related to Alzheimer's disease, their role in neurodegeneration and biomarker discovery

A. Güntert, 2006 .

Quantification of the A beta peptide in Alzheimer's plaques by laser dissection microscopy combined with mass spectrometry.

B. Bohrmann, A. Ducret, H. Döbeli, 2005, Journal of mass spectrometry : JMS.

Plasma transthyretin as a candidate marker for Alzheimer's disease.

Anna Kinsey, Simon Lovestone, Latha Velayudhan, 2012, Journal of Alzheimer's disease : JAD.

Proteomics of Alzheimer’s disease: understanding mechanisms and seeking biomarkers

S. Lovestone, M. Ward, M. Thambisetty, 2007, Expert review of proteomics.

Inflammatory Proteins in Plasma Are Associated with Severity of Alzheimer’s Disease

A. Simmons, H. Soininen, L. Wahlund, 2013, PloS one.

Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progression.

Magda Tsolaki, Bruno Vellas, Andrew Simmons, 2011, Journal of Alzheimer's disease : JAD.

High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain

B. Bohrmann, H. Döbeli, A. Güntert, 2006, Neuroscience.

Converging or Crossing Curves: Untie the Gordian Knot or Cut it? Appropriate Statistics for Non-Proportional Hazards in Decitabine DACO-016 Study (AML)

P. De Porre, A. Güntert, C. Tapprich, 2015, Advances in Therapy.